Drug Discovery & Development | Use of twice-daily pill could turn deadly blood cancer into highly treatable ... News-Medical.net They found that those who received the combination of idelalsib and rituximab went longer without their disease worsening than those who received only rituximab, which has been the standard of care. Six months into the study, cancers in 93 percent of ... New pill can 'melt away' leukemia without chemotherapy A pill may replace chemotherapy in treating leukemia |
